Reister, Andrea
`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Counsel,
`
`Trials <Trials@USPTO.GOV>
`Thursday, August 03, 2017 4:38 PM
`Olinger, Jonathan; Trials
`Mylan-WC-IPR; Stockwell, Mitch; Holloway, Clay; Baca, Mike; Parezo, Jessica; Reister,
`Andrea; Kamholz, Scott; maa@bskb.com; Herzbach, Lynde
`(Lynde.Herzbach@bskb.com) (Lynde.Herzbach@bskb.com)
`RE: IPR2017-00203: Request for Conference Call
`
`If the parties cannot reach agreement regarding the cross-examination of Patent Owner’s declarant, Mr. Masaru Tanjoh,
`then Petitioner is authorized to file a motion for additional discovery not later than Friday August 11th, such motion not to
`exceed 7 pages. Patent Owner may file an opposition within one week after the motion is filed, such opposition not to
`exceed 7 pages. No reply is authorized at this time.
`
`Regards,
`
`Andrew Kellogg,
`Supervisory Paralegal
`Patent Trial and Appeal Board
`USPTO
`andrew.kellogg@uspto.gov
`Direct: 571-272-5366
`
`From: Olinger, Jonathan [mailto:JOlinger@kilpatricktownsend.com]
`Sent: Thursday, August 03, 2017 2:56 PM
`To: Trials <Trials@USPTO.GOV>
`Cc: Mylan-WC-IPR <Mylan-WC-IPR@kilpatricktownsend.com>; Stockwell, Mitch
`<MStockwell@kilpatricktownsend.com>; Holloway, Clay <CHolloway@kilpatricktownsend.com>; Baca, Mike
`<MBaca@kilpatricktownsend.com>; Parezo, Jessica (jparezo@cov.com) <jparezo@cov.com>; Reister, Andrea
`(areister@cov.com) <areister@cov.com>; Kamholz, Scott (SKamholz@cov.com) <SKamholz@cov.com>; maa@bskb.com;
`Herzbach, Lynde (Lynde.Herzbach@bskb.com) (Lynde.Herzbach@bskb.com) <Lynde.Herzbach@bskb.com>
`Subject: IPR2017-00203: Request for Conference Call
`
`IPR2017-00203
`Patent No. 6,649,180
`Petitioner: Mylan Pharmaceuticals Inc.
`Patent Owner: Qualicaps Co. Ltd.
`
`Dear Board,
`
`Petitioner requests a telephone conference with the Board.
`
`In Patent Owner’s Response, Patent Owner relies on a declaration from Inventor Masaru Tanjoh submitted during
`prosecution of the ‘180 patent. Petitioner has requested that Patent Owner make Mr. Tanjoh available for cross-
`examination. Patent Owner has refused to do so.
`
`1
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2061 - 1/2
`
`

`

`Petitioner requests that Mr. Tanjoh be presented for cross-examination as a part of routine discovery pursuant to 37
`CFR 42.51(b)(1). In the alternative, Petitioner requests permission to file a motion for additional discovery in the form
`of Mr. Tanjoh’s deposition pursuant to 37 CFR 42.51(b)(2).
`
`Counsel for Petitioner and Patent Owner are available for a teleconference tomorrow morning before 12 noon Eastern.
`
`Respectfully submitted,
`
`Jonathan Olinger
`Counsel for Petitioner
`
`
`
`
`
`
`Jonathan D. Olinger
`Kilpatrick Townsend & Stockton LLP
`Suite 2800 | 1100 Peachtree Street NE | Atlanta, GA 30309-4528
`office 404 745 2426 | fax 404 541 3326
`jolinger@kilpatricktownsend.com | My Profile | vCard
`
`
`
`
`Confidentiality Notice:
`This communication constitutes an electronic communication within the meaning of the Electronic Communications Privacy Act, 18 U.S.C. Section 2510, and its
`disclosure is strictly limited to the recipient intended by the sender of this message. This transmission, and any attachments, may contain confidential attorney-
`client privileged information and attorney work product. If you are not the intended recipient, any disclosure, copying, distribution or use of any of the information
`contained in or attached to this transmission is STRICTLY PROHIBITED. Please contact us immediately by return e-mail or at 404 815 6500, and destroy the
`original transmission and its attachments without reading or saving in any manner.
`
`
`***DISCLAIMER*** Per Treasury Department Circular 230: Any U.S. federal tax advice contained in this communication (including any attachments) is not
`intended or written to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or
`recommending to another party any transaction or matter addressed herein.
`
`2
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2061 - 2/2
`
`